| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Articles |
Department of Pediatrics, Division of Endocrinology (L.S., L.E.U.), and Departments of Physiology (P.K.L., K.M.H.) and Pediatrics (M.H.U.), University of North Carolina, Chapel Hill, North Carolina 27599
Address all correspondence and requests for reprints to: Dr. P. K. Lund, Department of Physiology, CB#7545 University of North Carolina, Chapel Hill, North Carolina 27599-7545. E-mail: empk{at}med.unc.edu
Cytokines and insulin-like growth factors (IGFs) are involved in the
induction and/or perpetuation of inflammatory bowel disease. The effect
of fasting on inflammatory bowel disease was studied in a mouse
experimental model of acute colitis caused by adding dextran sulfate
sodium (DSS) to drinking water. Animals were either fed ad
libitum or fasted (water only) for 2 days before death.
Inflammation and tissue damage, measured as a colitis activity score,
were markedly reduced in fasted (2.4 ± 0.1) compared to fed
(5.3 ± 0.1) DSS animals (P < 0.0001). Colon
interleukin-1ß (IL-1ß), IGF-I, and tumor necrosis factor-
messenger RNAs (mRNAs) were quantified by Northern blot hybridization
and expressed as a percentage of mRNA abundance in fed controls. In DSS
mice, IL-1ß mRNA was elevated in the fed group (954 ± 155%;
P < 0.001), but was suppressed in fasted animals
(71.1 ± 11%). IGF-I mRNA also was elevated in fed DSS mice
(421 ± 71%; P < 0.01). This increase was
attenuated in fasted DSS mice (202 ± 17%; P
< 0.01 compared to fed DSS mice). Tumor necrosis factor-
mRNA was
increased in fed DSS mice (162 ± 15%; P <
0.01), but was not significantly lower in fasted animals. By in
situ hybridization, IL-1ß mRNA was localized to the lamina
propria of colonic mucosa in fed DSS animals, but was not detectable in
other groups. We conclude that fasting has a protective effect on the
progression of acute DSS-induced colitis. This is associated with
decreased expression of IL-1ß and IGF-I mRNAs in the colon.
This article has been cited by other articles:
![]() |
Y. Ikeda, A. Murakami, Y. Fujimura, H. Tachibana, K. Yamada, D. Masuda, K.-i. Hirano, S. Yamashita, and H. Ohigashi Aggregated Ursolic Acid, a Natural Triterpenoid, Induces IL-1beta Release from Murine Peritoneal Macrophages: Role of CD36 J. Immunol., April 15, 2007; 178(8): 4854 - 4864. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Z. Michaylira, N. M. Ramocki, J. G. Simmons, C. K. Tanner, K. K. McNaughton, J. T. Woosley, C. J. Greenhalgh, and P. K. Lund Haplotype Insufficiency for Suppressor of Cytokine Signaling-2 Enhances Intestinal Growth and Promotes Polyp Formation in Growth Hormone-Transgenic Mice Endocrinology, April 1, 2006; 147(4): 1632 - 1641. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Theiss, J. G. Simmons, C. Jobin, and P. K. Lund Tumor Necrosis Factor (TNF) {alpha} Increases Collagen Accumulation and Proliferation in Intestinal Myofibroblasts via TNF Receptor 2 J. Biol. Chem., October 28, 2005; 280(43): 36099 - 36109. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fruchtman, J. G. Simmons, C. Z. Michaylira, M. E. Miller, C. J. Greenhalgh, D. M. Ney, and P. K. Lund Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G342 - G350. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Dahly, M. E. Miller, P. K. Lund, and D. M. Ney Postreceptor Resistance to Exogenous Growth Hormone Exists in the Jejunal Mucosa of Parenterally Fed Rats J. Nutr., March 1, 2004; 134(3): 530 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Williams, C. R. Fuller, J. Fagin, and P. K. Lund Mesenchymal IGF-I overexpression: paracrine effects in the intestine, distinct from endocrine actions Am J Physiol Gastrointest Liver Physiol, October 1, 2002; 283(4): G875 - G885. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Pucilowska, K. K. McNaughton, N. K. Mohapatra, E. C. Hoyt, E. M. Zimmermann, R. B. Sartor, and P. K. Lund IGF-I and procollagen alpha 1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1307 - G1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hartmann, C. Bidlingmaier, B. Siegmund, S. Albrich, J. Schulze, K. Tschoep, A. Eigler, H. A. Lehr, and S. Endres Specific Type IV Phosphodiesterase Inhibitor Rolipram Mitigates Experimental Colitis in Mice J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 22 - 30. [Abstract] [Full Text] |
||||
![]() |
R. Miceli, M. Hubert, G. Santiago, D.-L. Yao, T. A. Coleman, K. A. Huddleston, and K. Connolly Efficacy of Keratinocyte Growth Factor-2 in Dextran Sulfate Sodium-Induced Murine Colitis J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 464 - 471. [Abstract] [Full Text] |
||||
![]() |
J. G. Simmons, J. B. Pucilowska, and P. K. Lund Autocrine and paracrine actions of intestinal fibroblast-derived insulin-like growth factors Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G817 - G827. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Drucker, B. Yusta, R. P. Boushey, L. DeForest, and P. L. Brubaker Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis Am J Physiol Gastrointest Liver Physiol, January 1, 1999; 276(1): G79 - G91. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. LUND Molecular Basis of Intestinal Adaptation: The Role of the Insulin-like Growth Factor System Ann. N.Y. Acad. Sci., November 17, 1998; 859(1): 18 - 36. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |